New Jersey · 2026-2027 Regular Session · Bill
S 4194: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 4194 is a bill introduced in the New Jersey Senate on May 11, 2026. According to its official title, it concerns: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*. Primary sponsor: Joe Vitale (Democratic), Vin Gopal (Democratic), Raj Mukherji (Democratic). Most recent recorded action (June 30, 2026): Substituted by A4852 (ACS).
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Joe Vitale | Primary sponsor | Democratic | Senate | 19 |
| Vin Gopal | Primary sponsor | Democratic | Senate | 11 |
| Raj Mukherji | Primary sponsor | Democratic | Senate | 32 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Substituted by A4852 (ACS)
- Reported from Senate Committee as a Substitute, 2nd Reading
- Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee